Adenocarcinoma of prostate
Item
histologically diagnosis of prostate adenocarcinoma
boolean
C0007112 (UMLS CUI [1])
Surveillance Risk Prostate carcinoma
Item
being monitored by active surveillance for favourable risk prostate cancer
boolean
C0733511 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
Biopsy of prostate Tumor tissue sample Available
Item
tumour material from most recent prostate biopsy available with sample
boolean
C0194804 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
Transrectal ultrasound Biopsy Scheduled
Item
scheduled to have an active surveillance mandated transrectal ultrasound (trus) guided biopsy within 6 - 12 months of day 1 of the study
boolean
C0373345 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Malignant Neoplasms Previous
Item
previous malignancy in the past 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Therapeutic procedure Prostate carcinoma
Item
no previous or concurrent treatment for prostate cancer
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Transrectal ultrasound Biopsy Receive Unable
Item
inability to undergo trus biopsy
boolean
C0373345 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C1514756 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
ECOG performance status
Item
ecog > 2
boolean
C1520224 (UMLS CUI [1])
Liver disease
Item
known or previous history of liver disease
boolean
C0023895 (UMLS CUI [1])